These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 22114906

  • 1. Olmesartan medoxomil combined with hydrochlorothiazide improves 24-hour blood pressure control in moderate-to-severe hypertension.
    Rosenbaum D, Girerd X.
    Curr Med Res Opin; 2012 Feb; 28(2):179-86. PubMed ID: 22114906
    [Abstract] [Full Text] [Related]

  • 2. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K, Ogihara T, Saruta T, Kuramoto K, REZALT Study Group.
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study.
    Fogari R, Taddei S, Holm-Bentzen M, Baszak J, Melani L, Schumacher K.
    Clin Drug Investig; 2010 May; 30(9):581-97. PubMed ID: 20593911
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.
    Barrios V, Boccanelli A, Ewald S, Girerd X, Heagerty A, Krzesinski JM, Lins R, Rodicio J, Stefenelli T, Woittiez A, Böhm M.
    Clin Drug Investig; 2007 May; 27(8):545-58. PubMed ID: 17638395
    [Abstract] [Full Text] [Related]

  • 7. Effect of an olmesartan medoxomil-based treatment algorithm on systolic blood pressure in patients with stage 1 or 2 hypertension: a randomized, double-blind, placebo-controlled study.
    Kereiakes DJ, Maa JF, Shojaee A, Dubiel R.
    Am J Cardiovasc Drugs; 2010 May; 10(4):239-46. PubMed ID: 20653330
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.
    Mallion JM, Heagerty A, Laeis P.
    J Hypertens; 2007 Oct; 25(10):2168-77. PubMed ID: 17885562
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study.
    Punzi H, Neutel JM, Kereiakes DJ, Shojaee A, Waverczak WF, Dubiel R, Maa JF.
    Ther Adv Cardiovasc Dis; 2010 Aug; 4(4):209-21. PubMed ID: 20519261
    [Abstract] [Full Text] [Related]

  • 11. Adding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild-to-moderate hypertension.
    Sellin L, Stegbauer J, Laeis P, Rump LC.
    J Hypertens; 2005 Nov; 23(11):2083-92. PubMed ID: 16208152
    [Abstract] [Full Text] [Related]

  • 12. Effect of valsartan, hydrochlorothiazide, and their combination on 24-h ambulatory blood pressure response in elderly patients with systolic hypertension: a ValVET substudy.
    Duprez DA, Weintraub HS, Cushman WC, Purkayastha D, Zappe D, Samuel R, Izzo JL.
    Blood Press Monit; 2011 Aug; 16(4):186-96. PubMed ID: 21747241
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of an olmesartan medoxomil-based treatment algorithm in patients with hypertension and type 2 diabetes: analysis of diurnal blood pressure control as assessed by 24-hour ambulatory blood pressure monitoring.
    Kereiakes DJ, Neutel J.
    Ther Adv Cardiovasc Dis; 2010 Oct; 4(5):285-93. PubMed ID: 20801941
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J, Shojaee A, Maa JF.
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy.
    Hsueh WA, Shojaee A, Maa JF, Neutel JM.
    Curr Med Res Opin; 2012 Nov; 28(11):1809-18. PubMed ID: 23072496
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.
    Chrysant SG, Marbury TC, Robinson TD.
    J Hum Hypertens; 2003 Jun; 17(6):425-32. PubMed ID: 12764406
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients aged 65 years and older with stage 1 and 2 hypertension or isolated systolic hypertension.
    Germino FW, Neutel JM, Dubiel R, Maa JF, Chavanu KJ.
    Am J Cardiovasc Drugs; 2012 Oct 01; 12(5):325-33. PubMed ID: 22920048
    [Abstract] [Full Text] [Related]

  • 18. Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.
    Mallion JM, Omboni S, Barton J, Van Mieghem W, Narkiewicz K, Panzer PK, Puig JG, Stefanadis C, Zweiker R, Study Group.
    Blood Press Suppl; 2011 Apr 01; 1():3-11. PubMed ID: 21091270
    [Abstract] [Full Text] [Related]

  • 19. Use of 24-h ambulatory blood pressure monitoring to assess blood pressure control: a comparison of olmesartan medoxomil and amlodipine besylate.
    Chrysant SG, Marbury TC, Silfani TN.
    Blood Press Monit; 2006 Jun 01; 11(3):135-41. PubMed ID: 16702822
    [Abstract] [Full Text] [Related]

  • 20. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
    Vaïsse B, Ghobrial H, Vaur L, Poncelet P, Asmar R, Herpin D, Mallion JM.
    Arch Mal Coeur Vaiss; 2001 Aug 01; 94(8):907-12. PubMed ID: 11575229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.